Search Results - ibrahim+abd-elazem

2 Results

Sort By:

Development of a Combinational Paradigm Combating HIV, HIV/HSV or HIV/HPV Infections in Humans

Technical Details: WHO report has stated that there are 39.5 million people currently HIV positive worldwide. Of these, 4.3 million have been infected in the year 2006 alone. AIDS death reached 2.9 million this year which is the highest ever reported in any year. There are 40,000 new AIDS cases a year in U.S. along. The anti-HIV compounds that are currently...

Published: 3/13/2025 | Inventor(s): Ru Chih Huang, Ibrahim Abd-Elazem

Keywords(s): Antagonists/Inhibitors, Cancers, Disease Indication, Herpes Simplex Virus, Herpes Simplex Virus (HSV), HIV, HIV/AIDS, Infectious Diseases, Natural compounds, Non-novel, Predicted Novelty, Small Molecules, Therapeutic Matter, Therapeutic Substance, Therapeutics, Viral Infections

Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Infectious Diseases > Herpes Simplex Virus, Clinical and Disease Specializations > Infectious Diseases > HIV/AIDS, Clinical and Disease Specializations > Infectious Diseases > Viral Infections, Clinical and Disease Specializations > Oncology, Technology Classifications > Therapeutic Modalities > Small Molecules, Clinical and Disease Specializations > Infectious Diseases, Technology Classifications > Therapeutic Modalities

Antiviral Compositions and Methods of Use

Technical Details: This invention is related to isolation of two highly potent, non-toxic inhibitors against human immunodeficiency virus type 1 (HIV-1) integrase and viral replication. Two water soluble compounds, M522 and M532, have been discovered by isolating them from Salvia miltiorrhiza roots in purities of > 99.5 % as reported by NMR spectral...

Published: 3/13/2025 | Inventor(s): Ibrahim Abd-Elazem, Ru Chih Huang, Hongshan Chen

Keywords(s): Antagonists/Inhibitors, Disease Indication, HIV, HIV/AIDS, Infectious Diseases, Natural compounds, Non-novel, Predicted Novelty, Small Molecules, Therapeutic Matter, Therapeutic Substance, Therapeutics, Viral Infections

Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Infectious Diseases > HIV/AIDS, Clinical and Disease Specializations > Infectious Diseases > Viral Infections, Technology Classifications > Therapeutic Modalities > Small Molecules, Clinical and Disease Specializations > Infectious Diseases, Technology Classifications > Therapeutic Modalities